Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Visken
Vitamin B12
Vitamin D A.3. What are the metabolic and endocrine abnormalities in patients with 22q11 deletion syndrome and the attendant manifestations? A.4. What are the common clinical manifestations of ESRD? A.4. What are the functions of the skin? A.5. What electrolyte imbalances occur in patients with impaired renal function, and how are they treated? A.7. Are patients with renal disease at increased risk of cardiovascular disease? B.6. Are there any psychiatric medications he is taking that would impact your anesthetic care?
Vitamin K B.1. How would you assess this patient preoperatively? B.9. What coagulation abnormalities are present after TBI? What modalities can be used to provide hemostasis and reduce intracranial hematoma expansion? C.10. If this patient had a massive blood loss, what blood replacement therapy would be indicated? C.11. What is the role of recombinant activated factor VII (rFVIIa) in the hemorrhaging obstetric patient? C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.9. Two hours later, estimated blood loss (EBL) is approximately 2 L and the patient has been resuscitated with 3 units of packed red blood cells (pRBCs), 229 mL intraoperative cell salvage (cell saver), and 500 mL albumin in addition to 4 L crystalloid. The surgeon says the field is still "oozy" and there is ongoing blood loss. What are your concerns for resuscitation moving forward? How will you guide your resuscitation?
Warfarin A.12. What recommendations for placement and removal of the epidural catheter would you make if this patient is on antiplatelet or anticoagulant therapy or if thromboprophylaxis is planned? B.1. How would you assess this patient preoperatively? B.1. What is dabigatran (Pradaxa)? How is its effect measured? How far in advance of elective surgery should it be stopped? Can its effect be reversed? B.2. How should his anticoagulation be managed during ECT? C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.5. This patient is to be heparinized intraoperatively, and anticoagulation might be continued postoperatively. Is this a contraindication to the preoperative placement of either an epidural or intrathecal catheter? What if the patient is receiving anticoagulants in the preoperative period? C.9. Two hours later, estimated blood loss (EBL) is approximately 2 L and the patient has been resuscitated with 3 units of packed red blood cells (pRBCs), 229 mL intraoperative cell salvage (cell saver), and 500 mL albumin in addition to 4 L crystalloid. The surgeon says the field is still "oozy" and there is ongoing blood loss. What are your concerns for resuscitation moving forward? How will you guide your resuscitation? D.8. How would you treat posttransplant bleeding?
Welchol
Zafirlukast
Zaleplon
Zinc A.13. Is CO2 soluble in water or plasma? Is it soluble in blood? Why? C.II-9. What are the advantages and disadvantages of hemodilution?
Zolpidem